TWD 30.0
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 377.4 Million TWD | 0.42% |
2022 | 375.83 Million TWD | -5.38% |
2021 | 397.18 Million TWD | 0.46% |
2020 | 395.38 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 460.63 Million TWD | 22.05% |
2024 Q2 | 464.17 Million TWD | 0.77% |
2023 Q3 | 379.44 Million TWD | -4.15% |
2023 Q2 | 395.86 Million TWD | 9.77% |
2023 FY | 377.4 Million TWD | 0.42% |
2023 Q1 | 360.62 Million TWD | 0.0% |
2023 Q4 | 377.4 Million TWD | -0.54% |
2022 Q4 | - TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Allied Biotech Corporation | 796.6 Million TWD | 52.623% |
GeneFerm Biotechnology Co., Ltd. | 152.07 Million TWD | -148.164% |
Easywell Biomedicals, Inc. | 386.34 Million TWD | 2.313% |
TTY Biopharm Company Limited | 1.91 Billion TWD | 80.293% |
Synmosa Biopharma Corporation | 2.43 Billion TWD | 84.532% |
Orient EuroPharma Co., Ltd. | 4.84 Billion TWD | 92.206% |
Center Laboratories, Inc. | 5.62 Billion TWD | 93.289% |
Tien Liang BioTech Co., Ltd. | 84.65 Million TWD | -345.794% |
Orient Pharma Co., Ltd. | 716.92 Million TWD | 47.358% |
InnoPharmax Inc. | 21.49 Million TWD | -1655.454% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 160.83 Million TWD | -134.659% |
DV Biomed Co., Ltd. | 387.69 Million TWD | 2.654% |
Foresee Pharmaceuticals Co., Ltd. | 228.25 Million TWD | -65.342% |
Handa Pharmaceuticals, Inc. | 13.24 Million TWD | -2750.491% |
UniPharma Co., Ltd. | 277 Thousand TWD | -136147.292% |
Anxo Pharmaceutical Co., Ltd. | 787.84 Million TWD | 52.096% |
Alar Pharmaceuticals Inc. | 1.4 Million TWD | -26685.309% |
Winston Medical Supply Co., Ltd. | 107.32 Million TWD | -251.634% |
Mercury Biopharmaceutical Corporation | 42.34 Million TWD | -791.178% |
Bioray Biotech Co., Ltd | 69.79 Million TWD | -440.757% |
TSH Biopharm Corporation Limited | 7.84 Million TWD | -4711.998% |